Related Experiment Video

Updated: Aug 20, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Inhibition of gastric cancer angiogenesis by vector-based RNA interference for Raf-1

Fanping Meng1, Jie Ding, Na Liu

  • 1Institude of Digestive Disease, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi Province, PR, China.

Cancer Biology & Therapy
|January 22, 2005
PubMed

Insights

Targeting Raf-1 kinase in gastric cancer cells inhibits tumor angiogenesis. Reducing Raf-1 levels suppressed key growth factors, increased cancer cell death, and slowed proliferation, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor angiogenesis is crucial for solid tumor growth and metastasis.
  • Raf-1 kinase has been implicated in regulating genes that promote angiogenesis.

Purpose of the Study:

  • To investigate the role of Raf-1 in gastric cancer angiogenesis.
  • To explore targeting Raf-1 as a therapeutic strategy for tumor angiogenesis.

Main Methods:

  • Utilized small interference RNA (siRNA) to reduce Raf-1 gene expression in SGC7901 gastric cancer cells.
  • Quantified changes in Raf-1 protein levels, vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1 alpha (HIF-1alpha).
  • Assessed effects on gastric cancer cell apoptosis and proliferation.

Main Results:

  • Raf-1 specific siRNA significantly decreased Raf-1 protein levels in SGC7901 cells.
  • Downregulation of Raf-1 led to reduced expression of VEGF and HIF-1alpha.
  • Targeting Raf-1 increased apoptosis and inhibited proliferation in transfected gastric cancer cells.

Conclusions:

  • Raf-1 plays a significant role in regulating angiogenesis by controlling key angiogenesis factors.
  • Targeting Raf-1 represents a potential therapeutic approach for inhibiting tumor angiogenesis in gastric cancer.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...